← Back to headlines
Merck Strikes Nearly $6 Billion Deal to Acquire Cancer Biotech Terns
Pharmaceutical giant Merck has reached an agreement for a deal valued at nearly $6 billion to acquire Terns, a biotechnology company focused on cancer research.
26 Mar, 08:02 — 26 Mar, 08:02
Sources
Showing 1 of 1 sources
Related Stories
Dutch Health Agency Warns of Potentially Fatal Trump-Shaped Ecstasy Pills
1h ago
48-Year-Old Anesthesiologist Found Dead in Greek Hospital On-Call Room
3h ago
Art World Mourns Yayoi Kusama as Tributes Highlight Her Lasting Creative Legacy
4h ago
Study Reveals Hidden Arterial Calcification in Young Adults
5h ago